PDCD1 and colorectal carcinoma: We co-cultured patient-derived CRC microtumors with autologous CFSE-labeled PBMCs and treated them with pembrolizumab (defined as microtumors + PBMCs + anti-PD-1) at 20 μg/mL under perfusion.